Answers are grounded in this paper and cite their sources.
Objectives Osmotic demyelination syndrome (ODS) is a rare neurological disorder caused by destruction of the myelin sheath in areas of the brain that are more susceptible to osmotic stress. Extrapontine and central pontine myelinolysis are rare events in children and are most commonly associated with rapid correction of hyponatremia.¹ Our report highlights the role of high dose methylprednisolone and immunoglobulin for the treatment of ODS in children. Methods Initial presentation: A 2-year old girl admitted to ED with a 3-week history of vomiting, weight loss and dehydration. The child had a background of high output ileostomy and short-gut syndrome secondary to gastroschisis and multiple laparotomies. At admission, the serum sodium was 97 mmol/L. The investigations suggested chronic hyponatraemia associated with fluid losses and long-standing increased water intake. Management: The patient required a hypertonic saline bolus and was admitted to the intensive care unit for complex fluid management due to her variable ongoing stoma losses. She was started on fluids for maintenance and deficit. Despite planned slow correction, she had an unintentional rapid correction of sodium of 15 mmol/L in 12 hours. After 72 hours, she had reduced power in her limbs, hypertonia and increased lethargy, and a diagnosis of ODS was considered. MRI confirmed basal ganglia oedema consistent with extra-pontine myelinolysis. The patient was jointly managed with the paediatric neurology team and a literature review was conducted. This included case reports from adult patients but with similar presentations and etiology of ODS.² ³ She was initiated on high-dose methylprednisolone for three days followed by a quick weaning plan with oral steroids. Following further discussion, she was managed with intravenous immunoglobulin, 2g/kg over 24–36 hours. Results She showed immediate neurological improvement with reduced irritability and improved tone and power in limbs. She was discharged with supportive management under the physiotherapy, occupational therapy and speech and language therapy teams. She had ongoing Neurology follow-up and had recovered to her neurological baseline within 6 months. Conclusion Learning Improved awareness of the difference in presentation between acute hyponatraemia and chronic hyponatraemia. The importance of strict fluid balance and serum sodium monitoring during imbalance correction to reduce risk of ODS, especially in children with a more complex background. Vigilance on behalf of clinical team to identify early signs of ODS Proposed treatment for ODS in children with high dose intravenous steroid and intravenous immunoglobulin with good outcomes demonstrated in the clinical setting. References Bansal LR, Zinkus T. Osmotic Demyelination Syndrome in Children. Pediatr Neurol. 2019 Aug;97:12–17. doi: 10.1016/j.pediatrneurol.2019.03.018. Epub 2019 Mar 28. PMID: 31128892. Innovative Multi-Approach Therapy for Treatment of Extrapontine Myelinolysis, ) April 14, 2020;94(15 Supplement). Kalampokini S, Artemiadis A, Zis P, Hadjihannas L, Parpas G, Kyrri A, Hadjigeorgiou GM. Osmotic demyelination syndrome improving after immune-modulating treatment: Case report and literature review. Clin Neurol Neurosurg. 2021 Sep;208:106811. doi: 10.1016/j.clineuro.2021.106811. Epub 2021 Jul 24. PMID: 34358802.
No takes yet. Share an insight, caveat, or question.
Shrikhande et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: